Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 254 of the 264 references it cites were found in a registry or an index; 169 of the 403 sources its claims cite were checked for support.

Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination

Open access

Abstract

Vitamin C (L-ascorbic acid) has been known as an antioxidant for most people. However, its physiological role is much larger and encompasses very different processes ranging from facilitation of iron absorption through involvement in hormones and carnitine synthesis for important roles in epigenetic processes. Contrarily, high doses act as a pro-oxidant than an anti-oxidant. This may also be the reason why plasma levels are meticulously regulated on the level of absorption and excretion in the kidney. Interestingly, most cells contain vitamin C in millimolar concentrations, which is much higher than its plasma concentrations, and compared to other vitamins. The role of vitamin C is well demonstrated by miscellaneous symptoms of its absence-scurvy. The only clinically well-documented indication for vitamin C is scurvy. The effects of vitamin C administration on cancer, cardiovascular diseases, and infections are rather minor or even debatable in the general population. Vitamin C is relatively safe, but caution should be given to the administration of high doses, which can cause overt side effects in some susceptible patients (e.g., oxalate renal stones). Lastly, analytical methods for its determination with advantages and pitfalls are also discussed in this review.

Overview

CoChat Summary

TL;DR

Vitamin C (L-ascorbic acid) is an essential water-soluble vitamin with broad cofactor roles, tightly regulated absorption/excretion, and scurvy as its only clinically well-documented indication. High-dose intravenous use may have pro-oxidant anticancer potential, but evidence for cancer, cardiovascular disease, and infections is limited or debatable, and high doses carry rare risks such as oxalate stones.

Key findings

  • Humans cannot synthesize vitamin C because they lack L-gulono-1,4-lactone oxidase; body content is about 1.5 g (~20 mg/kg), recommended intakes vary from 40 to 120 mg/day, and about 10 mg/day prevents scurvy.
  • Absorption is saturable via SVCT1: bioavailability is 100% at 200 mg, about 73% at 500 mg, and about 50% at 1.25 g; plasma levels average 40–65 µM, maximal steady-state oral levels are 70–85 µM, and most cells contain 0.5–5 mM, with neurons reaching 10 mM.
  • Scurvy is associated with plasma vitamin C below 11 µM and total body content below 300–400 mg; the only clinically well-documented indication for vitamin C is scurvy, while effects on cancer, cardiovascular diseases, and infections are minor or debatable in the general population.
  • Toxicity is generally low, but a single oral dose of 5–10 g can cause osmotic diarrhea/bloating; a prospective cohort found oral vitamin C above 1 g/day increased stone formation risk by 41%, and high doses can precipitate hemolysis in glucose-6-phosphate dehydrogenase deficiency and rebound scurvy in newborns.

Methods

  • Design: narrative review of vitamin C covering sources, physiological role, kinetics, deficiency, therapeutic use, toxicity, and analytical determination.
  • Data: published literature, including human, animal, in vitro, clinical trial, and analytical method studies; no primary sample or systematic search strategy is reported.
  • Analysis: qualitative synthesis of evidence, with selected numerical values from cited studies and a table of analytical methods for human biofluids.

Limitations

  • The paper states that high-quality placebo-controlled clinical trials are crucially needed to verify vitamin C effects in cancer treatment and prevention, that data on clinical outcomes in cardiac surgery patients are insufficient, and that the global significance of SLC23A1/SLC23A2 SNPs needs further investigation.
  • The paper notes that determination of vitamin C in biological material is difficult due to instability, interference, and lack of routine internal standards, and that electrochemical sensors have not been tested in routine practice or large clinical studies.
  • Evident from the text: as a narrative review without a described systematic search or formal quality assessment, it may be subject to selection bias and does not provide quantitative pooled estimates.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu13020615

Cites

254 of 254 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Optical isomers of vitamin C. (A) L-ascorbic acid, (B) erythorbic acid, and (C) D-ascorbic acid. Differences are shown in red and blue.
Figure 1 Optical isomers of vitamin C. (A) L-ascorbic acid, (B) erythorbic acid, and (C) D-ascorbic acid. Differences are shown in red and blue.CC BY · PubMed Central
Figure 2 Vitamin C kinetics in the human body. (A): Absorption in the gastrointestinal tract. In the distal ileum, the absorption of ascorbate is mediated via SVCT1, while in the upper parts of the GIT, where pH is lower, the passive diffusion of non-ionized ascorbic acid is also possible. Absorption of dehydroascorbic acid does not seem to contribute significantly and is not shown. (B): reabsorption of vitamin C through the proximal tubules to the blood. Passive diffusion is also possible in acidic urine, likely in other parts of the urinary tract, but it does not seem to contribute significantly to vitamin C reabsorption and is, hence, not shown. (C): Distribution of vitamin C to most cells. (D): Distribution of vitamin C to the neurons. There are no specific transporters for ascorbate in the blood-brain barrier. Hence, the only possible way is the uptake and release of vitamin C in the form of dehydroascorbic acid via glucose transporters (GLUT). This transport is likely not the major contributor of vitamin C distribution to the brain (see corresponding part of the article). Contrarily, in the choroid plexus, the SVCT2 is expressed and this seems to be the major pathway for vitamin C kinetics to the brain. Neurons are also expressing SVCT2.
Figure 2 Vitamin C kinetics in the human body. (A): Absorption in the gastrointestinal tract. In the distal ileum, the absorption of ascorbate is mediated via SVCT1, while in the upper parts of the GIT, where pH is lower, the passive diffusion of non-ionized ascorbic acid is also possible. Absorption of dehydroascorbic acid does not seem to contribute significantly and is not shown. (B): reabsorption of vitamin C through the proximal tubules to the blood. Passive diffusion is also possible in acidic urine, likely in other parts of the urinary tract, but it does not seem to contribute significantly to vitamin C reabsorption and is, hence, not shown. (C): Distribution of vitamin C to most cells. (D): Distribution of vitamin C to the neurons. There are no specific transporters for ascorbate in the blood-brain barrier. Hence, the only possible way is the uptake and release of vitamin C in the form of dehydroascorbic acid via glucose transporters (GLUT). This transport is likely not the major contributor of vitamin C distribution to the brain (see corresponding part of the article). Contrarily, in the choroid plexus, the SVCT2 is expressed and this seems to be the major pathway for vitamin C kinetics to the brain. Neurons are also expressing SVCT2.CC BY · PubMed Central
Figure 3 Relationship between a dose of vitamin C and bioavailability in humans. The data are from three studies—1 Graumlich et al. 1997 [57], 2 Levine et al., 1996 [55], and 3 Hornig et al., 1980 [56].
Figure 3 Relationship between a dose of vitamin C and bioavailability in humans. The data are from three studies—1 Graumlich et al. 1997 [57], 2 Levine et al., 1996 [55], and 3 Hornig et al., 1980 [56].CC BY · PubMed Central
Figure 4 Dehydroascorbic acid and its decomposition. Dehydroascorbic acid (A) forms reversibly a hemiketal (B, a spatial structure shown in brackets). The structure is not stable and it is irreversibly transformed in 2,3-diketo-1-gulonic acid (C). This compound can be decarboxylated into L-xylonic acid (D) or L-lyxonic acid (E) or in L-erythrulose (F) and oxalate (G). 1: the reaction can be both spontaneous or mediated by an enzyme. 2: No enzyme mediating this reaction was reported. The reaction is likely spontaneous.
Figure 4 Dehydroascorbic acid and its decomposition. Dehydroascorbic acid (A) forms reversibly a hemiketal (B, a spatial structure shown in brackets). The structure is not stable and it is irreversibly transformed in 2,3-diketo-1-gulonic acid (C). This compound can be decarboxylated into L-xylonic acid (D) or L-lyxonic acid (E) or in L-erythrulose (F) and oxalate (G). 1: the reaction can be both spontaneous or mediated by an enzyme. 2: No enzyme mediating this reaction was reported. The reaction is likely spontaneous.CC BY · PubMed Central
Figure 5 The summary of physiological functions of vitamin C.
Figure 5 The summary of physiological functions of vitamin C.CC BY · PubMed Central
Figure 6 The reaction catalyzed by human 4-hydroxyphenylpyruvate dioxygenase. 4-hydroxyphenylpyruvate is oxidized by molecular oxygen by the enzyme in the presence of ascorbate. The products of this reaction are homogentisate (2,5-dihydroxyphenylacetate) and carbon dioxide. The origin of oxygen is highlighted in a blue and red color.
Figure 6 The reaction catalyzed by human 4-hydroxyphenylpyruvate dioxygenase. 4-hydroxyphenylpyruvate is oxidized by molecular oxygen by the enzyme in the presence of ascorbate. The products of this reaction are homogentisate (2,5-dihydroxyphenylacetate) and carbon dioxide. The origin of oxygen is highlighted in a blue and red color.CC BY · PubMed Central
Figure 7 Amidation catalysed by peptidyl-glycine α-amidating monooxygenase (PAM) -the likely mechanism. 1: Ascorbic acid reduces cupric ions in the active site of the peptidyl-glycine α-hydroxylating monooxygenase domain (shown in light blue). 2: two molecules of ascorbic acid are oxidized to ascorbyl radical (2a) and the active enzyme with reduced cuprous ions in the active site is formed (2b). 3: This active site binds the substrate and needs oxygen for the reaction as well. 4: One oxygen is incorporated in the water while the second is incorporated in the substrate. 5: The reaction continues, with the binding of the hydroxylated site to the active center with a zinc atom of the α-hydroxyglycine α-amidating lyase domain of the enzyme (shown in dark blue). 6: This results in the production of the α-amidated enzyme and the release of glyoxylate.
Figure 7 Amidation catalysed by peptidyl-glycine α-amidating monooxygenase (PAM) -the likely mechanism. 1: Ascorbic acid reduces cupric ions in the active site of the peptidyl-glycine α-hydroxylating monooxygenase domain (shown in light blue). 2: two molecules of ascorbic acid are oxidized to ascorbyl radical (2a) and the active enzyme with reduced cuprous ions in the active site is formed (2b). 3: This active site binds the substrate and needs oxygen for the reaction as well. 4: One oxygen is incorporated in the water while the second is incorporated in the substrate. 5: The reaction continues, with the binding of the hydroxylated site to the active center with a zinc atom of the α-hydroxyglycine α-amidating lyase domain of the enzyme (shown in dark blue). 6: This results in the production of the α-amidated enzyme and the release of glyoxylate.CC BY · PubMed Central
Figure 8 Interconnection between antioxidant effects of vitamin C and E. (A): Unsaturated fatty acid within the LDL (low-density lipoproteins) particle is oxidized (e.g., by other ROS, 1). (B): The lipid peroxy radical formed is neutralized by vitamin E (α-tocopherol, 2). (C): The reaction results in a lipid hydroperoxide (3) and the formation of the α-tocopheryl radical, which immediately reacts with vitamin C (ascorbate, 4). (D): This leads to the recovery of α-tocopherol (5) and the formation of an ascorbate free radical. Ascorbate can be recovered either via dehydroascorbic acid (6) or directly (7). The are several ways how these reactions can be accomplished either non-enzymatically or enzymatically.
Figure 8 Interconnection between antioxidant effects of vitamin C and E. (A): Unsaturated fatty acid within the LDL (low-density lipoproteins) particle is oxidized (e.g., by other ROS, 1). (B): The lipid peroxy radical formed is neutralized by vitamin E (α-tocopherol, 2). (C): The reaction results in a lipid hydroperoxide (3) and the formation of the α-tocopheryl radical, which immediately reacts with vitamin C (ascorbate, 4). (D): This leads to the recovery of α-tocopherol (5) and the formation of an ascorbate free radical. Ascorbate can be recovered either via dehydroascorbic acid (6) or directly (7). The are several ways how these reactions can be accomplished either non-enzymatically or enzymatically.CC BY · PubMed Central
Figure 9 Vitamin C, tetrahydrobiopterin, and endothelial NO-synthase (eNOS). (A): normal conditions, (B): lack of vitamin C and oxidative stress, (C): physiological levels of vitamin C and oxidative stress in the vascular system, (D): i.v. administration of high vitamin C doses. Under normal conditions, tetrahydrobiopterin (BH4) is used by the eNOS for the synthesis of NO (1). Trihydrobiopterin radical (BH3.) can be generated by eNOS. It can be recovered to BH4 by both eNOS itself or ascorbate (2). Ascorbate is recovered from the ascorbyl radical (3) by several pathways discussed in this article. Under the lack of vitamin C and under oxidative stress, BH4 is oxidized by reactive oxygen species (ROS). This decreases the availability of this cofactor and may lead to the formation of dihydrobiopterin (BH2, 4). BH2 can be reduced back to BH4 by dihydrofolate reductase (5). Similarly, if BH3. cannot be recovered to BH4, it can be oxidized to dihydrobiopterin (BH2, 6). BH2 binds to eNOS, but causes uncoupling. Such an enzyme can no longer produce NO, but produces superoxide instead (7). Oxidative stress is demonstrated since elevated levels of superoxide in circulation cannot be normalized by physiological concentrations of vitamin C, which has a lower affinity to superoxide (8) than superoxide has to NO. As a result, the protective NO is reacting with superoxide into highly reactive peroxynitrite (9). Peroxynitrite can also oxidize BH4 (10) and cause eNOS uncoupling, as was shown in part B (No. 4). However, when vitamin C is given in high doses intravenously, it reaches mM levels and is considered to compete with NO for the superoxide (11). The superoxide is neutralized by such a high concentration of vitamin C and NO can exert its endothelial protective function.
Figure 9 Vitamin C, tetrahydrobiopterin, and endothelial NO-synthase (eNOS). (A): normal conditions, (B): lack of vitamin C and oxidative stress, (C): physiological levels of vitamin C and oxidative stress in the vascular system, (D): i.v. administration of high vitamin C doses. Under normal conditions, tetrahydrobiopterin (BH4) is used by the eNOS for the synthesis of NO (1). Trihydrobiopterin radical (BH3.) can be generated by eNOS. It can be recovered to BH4 by both eNOS itself or ascorbate (2). Ascorbate is recovered from the ascorbyl radical (3) by several pathways discussed in this article. Under the lack of vitamin C and under oxidative stress, BH4 is oxidized by reactive oxygen species (ROS). This decreases the availability of this cofactor and may lead to the formation of dihydrobiopterin (BH2, 4). BH2 can be reduced back to BH4 by dihydrofolate reductase (5). Similarly, if BH3. cannot be recovered to BH4, it can be oxidized to dihydrobiopterin (BH2, 6). BH2 binds to eNOS, but causes uncoupling. Such an enzyme can no longer produce NO, but produces superoxide instead (7). Oxidative stress is demonstrated since elevated levels of superoxide in circulation cannot be normalized by physiological concentrations of vitamin C, which has a lower affinity to superoxide (8) than superoxide has to NO. As a result, the protective NO is reacting with superoxide into highly reactive peroxynitrite (9). Peroxynitrite can also oxidize BH4 (10) and cause eNOS uncoupling, as was shown in part B (No. 4). However, when vitamin C is given in high doses intravenously, it reaches mM levels and is considered to compete with NO for the superoxide (11). The superoxide is neutralized by such a high concentration of vitamin C and NO can exert its endothelial protective function.CC BY · PubMed Central

Verification

Claims the paper makes

105 Valid · 10 Not valid · 68 Not checked · 48 Own results and interpretations

122 more claims · 58 with their cited sources checked

Create a free account to see all 231 claims and to verify the 20 references still open.

See all claims — free account
  • Probably not a substantial claim. 35
  • It may state two separate claims as one. 74

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 2

  1. Chakraborty, 2008, Biochemical composition of eight benthic alge collected from Sunderban, Indian J. Mar. Sci, 37, 329
  2. Nema, P.K., Kaur, B.P., and Mujumdar, A.S. (2018). The degradation mechanisms and kinetics of vitamin C in fruits and vegetables during thermal processing. Drying Technologies in Foods, CRC Press.

Cited by

See all 553

Metadata

Authors
Doseděl, M., Jirkovský, E., Macáková, K., Krčmová, L., Javorská, L., Pourová, J., Mercolini, L., Remião, F., Nováková, L., Mladěnka, P., & OEMONOM, O. B. O. T.
Affiliations
  • Charles University (CZ)
  • University Hospital Hradec Králové (CZ)
  • University of Bologna (IT)
  • Universidade do Porto (PT)
Corresponding author
Mladěnka, Přemysl
Venue
Nutrients
Publisher
MDPI AG
Published
2021-02-13
Volume
13
Issue
2
Pages
615
ISSN
2072-6643 (ISSN-L)
OpenAlex
W3132713966
Cited by
553
References
264
Citations by year
2026: 90 · 2025: 146 · 2024: 162 · 2023: 97 · 2022: 44 · 2021: 13
FWCI
10.53
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Erasmus+ Programme (2020-1-CZ01-KA203-078218)
  • EFSA-CDN (CZ.02.1.01/0.0/0.0/16_019/0000841)
  • MH-CZ-DRO (00179906)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Vitamin C and Antioxidants Research
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
Keywords
vitamin C, scurvy, iron absorption, carnitine synthesis, epigenetics, pro-oxidant activity, vitamin C metabolism, vitamin C supplementation, vitamin C toxicity, vitamin C determination, antioxidants
MeSH terms
Antioxidants, Ascorbic Acid, Ascorbic Acid Deficiency, Humans, Kinetics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.